周德敏团队在可调控、通用型CAR-T干预自身免疫疾病和肿瘤的研究方面取得进展
北京大学药学院
The group of Demin Zhou has made progress in the research on the regulation and universal chimeric antigen receptor T (CAR-T) autoimmune diseases and tumors
School of Pharmaceutical Sciences, Peking University Health Science Center
中国药学(英文版)
.
2020, (10): 748
-749
.
>
>